IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q3 2021 Holdings

Filed 2021-11-12 | 4 holdings | $281.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
10x Genomics, Inc.(TXG)CLASS A COMMON88025U109$255.3K1,753,52890.7%
Novavax, Inc.(NVAX)COM670002401$14.0K67,3735.0%
Acceleron Pharma Inc.(XLRN)COM00434H108$7.9K45,8842.8%
Epizyme, Inc.(EPZMEUR)COM29428V104$4.3K832,3361.5%